New York, January 22, 2026, 18:56 EST — After-hours
- Shares of Thermo Fisher ended the day 0.5% higher at $639.43, with after-hours trading showing minimal movement
- The stock hit a fresh 52-week high during the session as Wall Street pushed its rally further
- Investors look to Jan. 29 earnings for clues on lab and biopharma spending
Shares of Thermo Fisher Scientific Inc (TMO) hit a fresh 52-week high Thursday, closing up 0.5% at $639.43. After hours trading saw little movement, with the stock at $639.45 following the 4 p.m. ET bell. During the session, prices fluctuated between $633.51 and $643.66. MarketWatch
The Waltham, Massachusetts-based firm is set to release its fourth-quarter and full-year 2025 results next Thursday. Investors see this report as a key indicator for lab spending trends. The company will hold a conference call at 8:30 a.m. ET that day. Thermo Fisher Scientific
The rally fits within a larger risk-on shift. Wall Street’s key indexes climbed again Thursday after U.S. President Donald Trump eased off tariff threats against European allies, and economic data showed the U.S. economy holding steady. Reuters
Thermo Fisher surged 2.79% on Wednesday, closing at $636.30 and hitting a 52-week high on heavier-than-usual volume, MarketWatch data showed. MarketWatch
Late Thursday, peers showed a mixed picture. Danaher and Agilent slipped roughly 0.8% from their previous closes, whereas Waters edged up nearly 1%.
Next week, the focus won’t be on daily trading but on the tone companies set in their guidance. Investors are looking for signs that customer budgets are opening up again following a turbulent period for biotech funding and research tool purchases.
Chief Executive Marc Casper highlighted the push for “reshoring” — bringing manufacturing back to the U.S. — as a key growth factor for the company’s pharmaceutical services. “There’s a very big focus on reshoring more production and activity to the U.S.,” Casper told the J.P. Morgan Healthcare Conference earlier this month. Reuters
Thermo Fisher is also betting on lab automation as a key growth driver. “Artificial intelligence coupled with laboratory automation will transform how scientific work is performed,” said executive vice president Gianluca Pettiti in a January 12 statement about the company’s strategic tie-up with Nvidia. Thermo Fisher Scientific
But the setup works both ways. Shares hovering near a fresh high leave little room for error—any cautious forecasts, a slowdown in orders, or a sudden spike in policy-driven volatility could send the stock tumbling fast.
The next major event to watch is Jan. 29, when Thermo Fisher reports earnings before the market opens and hosts its conference call at 8:30 a.m. ET.
